Press release
March 3, 2026
PepGen to Participate in the Leerink Global Healthcare Conference
PepGen Inc. (PEPG)
BOSTON --(BUSINESS WIRE)--Mar. 3, 2026-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur,